Schein ousts top executives suddenly to simplify business and improve execution on its goals with new leadership team.
Siemens Healthineers and Cleveland Clinic extend their 10-year partnership to advance diagnostic and therapeutic technologies for better patient care.
Robotic microsurgery is being tested for Alzheimer's treatment with FDA clearance for expanded enrollment in a feasibility trial using robotic systems.
Stryker recovers from recent cyber attack that disrupted operations and affected first-quarter results.
FDA reconsiders artificial intelligence use after commissioner departure, focusing on ai strategy and implementation, while ensuring regulatory compliance.
Johnson & Johnson’s Ottava surgical robot gains FDA clearance, boosting precision in general surgery and challenging da Vinci’s dominance.
Medtronic invests $37M in CoreMap to advance cardiac mapping technology for precise AFib treatment, improving ablation outcomes.
Boston Scientific trims 2026 sales and earnings guidance due to slowing growth in key product lines, including Watchman and electrophysiology, affecting its…
Abbott launches a comprehensive heart valve study assessing its TriClip device's real-world safety and performance in treating tricuspid valves.
Boston Scientific restructuring plan will incur up to $800 M in pre‑tax charges as the company shifts production and cuts jobs to…